Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mainz Biomed N.V. - Ordinary Shares
(NQ:
MYNZ
)
0.7800
-0.0668 (-7.89%)
Streaming Delayed Price
Updated: 1:08 PM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
241,183
Open
0.8484
Bid (Size)
0.7350 (100)
Ask (Size)
0.7900 (300)
Prev. Close
0.8468
Today's Range
0.7000 - 0.8484
52wk Range
0.6000 - 8.164
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
January 14, 2026
First data on blood-based mRNA signature for pancreatic ductal adenocarcinoma (PDAC) detection and intraductal papillary mucinous neoplasms (IPMN) differentiation to be presented in San Diego
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Provides Review of 2025 Highlights
January 05, 2026
From
Mainz BioMed NV
Via
GlobeNewswire
Performance
YTD
-32.8%
-32.8%
1 Month
-33.3%
-33.3%
3 Month
-42.6%
-42.6%
6 Month
-54.7%
-54.7%
1 Year
-90.1%
-90.1%
More News
Read More
2 Small-Cap Biotechs That Could Reward Patient Investors
↗
December 12, 2025
Via
MarketBeat
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
December 03, 2025
Via
Chartmill
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
December 02, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
November 18, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
November 13, 2025
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
November 12, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
November 10, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed to Attend 2025 Maxim Growth Summit
October 15, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
October 08, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
September 30, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
September 23, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
September 02, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
August 13, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
August 04, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 01, 2025
Via
Benzinga
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
July 23, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 16, 2025
Via
Benzinga
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
July 15, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
June 25, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
June 10, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
May 19, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Frequently Asked Questions
Is Mainz Biomed N.V. - Ordinary Shares publicly traded?
Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.
What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?
Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?
The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market
What is the current price of Mainz Biomed N.V. - Ordinary Shares?
The current price of Mainz Biomed N.V. - Ordinary Shares is 0.7800
When was Mainz Biomed N.V. - Ordinary Shares last traded?
The last trade of Mainz Biomed N.V. - Ordinary Shares was at 02/12/26 01:08 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
